home / stock / cccc / cccc articles
Kelly Schick, Chief People Officer at C4 Therapeutics (NASDAQ:CCCC), reported a large acquisition of company stock options on September 19, accordi...
News, Short Squeeze, Breakout and More Instantly...
C4 Therapeutics Inc. Company Name:
CCCC Stock Symbol:
NASDAQ Market:
Cooper Brings Decades of Global Pharmaceutical and Biotechnology Leadership Experience Bruce Downey Remains a Member of the Board of Directors and Chair of the Organization, Leadership and Compensation Committee Transition Further Highlights Commitment to Strategically Transform t...
Successfully Delivered First Development Candidate to Biogen; $8 Million Payment Earned Established a Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Focused on Two Critical Oncogenic Proteins Progressed Phase 1 Dose Escalation Trials for Cemsidom...